Akèy › Limfòm selil-T kutane › Texas › Houston
Etid klinik pou Limfòm selil-T kutane nan Houston, TX
5 etid pou Limfòm selil-T kutane ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Ap rekriteFaz 1
- Md Anderson Cancer Center, Houston
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
Ap rekriteFaz 2
- MD Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- MD Anderson Cancer Center (Data Collection Only), Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- The University of Texas MD Anderson Cancer Center, Houston
Etid Limfòm selil-T kutane nan lòt vil
- New York City, NY9 etid
- Baldwin Park, CA8 etid
- Boston, MA5 etid
- New Haven, CT4 etid
- Chicago, IL3 etid
- Ann Arbor, MI3 etid
- Scottsdale, AZ3 etid
- Durham, NC3 etid
- Tampa, FL3 etid
- Columbus, OH3 etid
- Rochester, MN3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.